Evaluating cardiac disorders associated with triazole antifungal agents based on the US Food and Drug Administration Adverse Event reporting system database

Evaluating cardiac disorders associated with triazole antifungal agents based on the US Food and Drug Administration Adverse Event reporting system database

Introduction:Triazole antifungal agents are widely used to treat and prevent systemic mycoses. With wide clinical use, the number of reported adverse events has gradually increased. The aim of this study was to analyze the cardiac disorders associated with TAAs (fluconazole, voriconazole, itraconazo...

Full description

Bibliographic Details
Main Authors: Jinhua Chen, Shijun Xu, Weijiang Yu, Cuicui Sun, Wenzhou Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Pharmacology
Subjects:
triazole antifungal agents
FAERS
cardiac disorders
adverse events
isavuconazole
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1255918/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1255918/full

Similar Items